1 unknown. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Unknown 1 |
Follow Artificial Intelligence: new trials by email Literature Review of Artificial Intelligence trials Research Report on Artificial Intelligence
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Neoadjuvant Camrelizumab, Nab-paclitaxel and Carboplatin in Stage IB-IIIA NSCLC Camrelizumab + Nab-paclitaxel + Carboplatin - Lung Cancer, Non-small Cell, Artificial Intelligence | Phase 2 | Unknown | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 40 | 2020-08-01 | 2021-06-23 |
Carcinoma, Non-Small-Cell Lung (1)
Bronchial Neoplasms (1) · Carcinoma, Bronchogenic (1) · Lung Diseases (1) · Lung Neoplasms (1) · Neoplasms (1) · Neoplasms by Site (1) · Respiratory Tract Diseases (1) · Respiratory Tract Neoplasms (1) · Thoracic Neoplasms (1)
130-nm albumin-bound paclitaxel (1) · Carboplatin (1) · camrelizumab (1)
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University (1)
China (1)